Cost-Effectiveness of Osteoporosis Treatment
Publisher
Springer Singapore
Reference41 articles.
1. Mueller D, Weyler E, Gandjour A. Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis. PharmacoEconomics. 2008;26(6):513–36.
2. Mueller D, Gandjour A. Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women. Appl Health Econ Health Policy. 2008;6(2–3):113–35.
3. Nayak S, Roberts MS, Greenspan SL. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med. 2011;155(11):751–61.
4. Nayak S, Roberts MS, Greenspan SL. Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment. PLoS One. 2012;7(3):e32879.
5. Nshimyumukiza L, Durand A, Gagnon M, Douville X, Morin S, Lindsay C, Duplantie J, Gagné C, Jean S, Giguère Y, Dodin S, Rousseau F, Reinharz D. An economic evaluation: simulation of the cost- effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res. 2013;28(2):383–94.